These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8608487

  • 1. Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma.
    Takeda H, Akakura K, Masai M, Akimoto S, Yatani R, Shimazaki J.
    Cancer; 1996 Mar 01; 77(5):934-40. PubMed ID: 8608487
    [Abstract] [Full Text] [Related]

  • 2. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG.
    J Urol; 1999 Apr 01; 161(4):1229-32. PubMed ID: 10081875
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications.
    Theodoropoulos VE, Tsigka A, Mihalopoulou A, Tsoukala V, Lazaris AC, Patsouris E, Ghikonti I.
    Urology; 2005 Oct 01; 66(4):897-902. PubMed ID: 16230178
    [Abstract] [Full Text] [Related]

  • 9. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
    Kupelian PA, Buchsbaum JC, Elshaikh M, Reddy CA, Zippe C, Klein EA.
    Cancer; 2002 Dec 01; 95(11):2302-7. PubMed ID: 12436435
    [Abstract] [Full Text] [Related]

  • 10. Expression of sialylated MUC1 in prostate cancer: relationship to clinical stage and prognosis.
    Arai T, Fujita K, Fujime M, Irimura T.
    Int J Urol; 2005 Jul 01; 12(7):654-61. PubMed ID: 16045558
    [Abstract] [Full Text] [Related]

  • 11. Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.
    Bass R, Perry B, Langenstroer P, Thrasher JB, Dennis KL, Tawfik O, Holzbeierlein J.
    J Urol; 2009 Feb 01; 181(2):615-9; discussion 619-20. PubMed ID: 19091346
    [Abstract] [Full Text] [Related]

  • 12. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R, Mazzucchelli R, Barbisan F, Stramazzotti D, Santinelli A, Scarpelli M, Lòpez Beltran A.
    Hum Pathol; 2006 Sep 01; 37(9):1137-44. PubMed ID: 16938518
    [Abstract] [Full Text] [Related]

  • 13. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA, Quast BJ, Wilson MJ, Fernandes ET, Reddy PK, Ewing SL, Gleason DF.
    Cancer; 2002 Jun 15; 94(12):3141-9. PubMed ID: 12115346
    [Abstract] [Full Text] [Related]

  • 14. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Macklis R, Klein E.
    Cancer J Sci Am; 1997 Jun 15; 3(2):78-87. PubMed ID: 9099457
    [Abstract] [Full Text] [Related]

  • 15. Distant metastases from prostatic carcinoma express androgen receptor protein.
    Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A.
    Cancer Res; 1995 Jul 15; 55(14):3068-72. PubMed ID: 7541709
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.
    Wikström P, Marusic J, Stattin P, Bergh A.
    Prostate; 2009 Jun 01; 69(8):799-809. PubMed ID: 19189305
    [Abstract] [Full Text] [Related]

  • 19. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival.
    Cheville JC, Tindall D, Boelter C, Jenkins R, Lohse CM, Pankratz VS, Sebo TJ, Davis B, Blute ML.
    Cancer; 2002 Sep 01; 95(5):1028-36. PubMed ID: 12209687
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.